ATHNdataset Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAmerican Thrombosis and Hemostasis Network

About this trial

The Hemophilia Treatment Center (HTC) where you receive care is working with The American Thrombosis and Hemostasis Network (ATHN) to look at the quality of life of people with blood disorders and problems.

Doctors, scientists, policymakers, and other health care providers need a large amount of information from a lot of people to answer scientific, public health, and policy questions about better ways to treat blood disorders. They will use the information from the ATHNdataset to answer these questions.

Eligibility criteria

Qualifiers

Any participant evaluated for or the potential to have a blood disorder who has an encounter with an ATHN Affiliate.

Participants of any age.

Participant is able to provide consent or assent; a Legally Authorized Representative (LAR) may provide consent on a participant's behalf if a participant is unable to provide self-consent

Disqualifiers

Any participant unable to provide consent or assent to participate in the ATHNdataset

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

200,000 Participants
are grouped into 1 trial group